Atlas Trials

Temsirolimus in Myelodysplastic Syndrome (MDS)

Clinical trial NCT01111448 · TERMINATED

Trial details

NCT number
NCT01111448
Sponsor
Technische Universität Dresden
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2010-04-01
Primary completion
2013-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.